tailieunhanh - Meta-analysis on resected pancreatic cancer: A comparison between adjuvant treatments and gemcitabine alone

Pancreatic cancer is a highly malignant tumor with a poor prognosis. Chemotherapy such as gemcitabine is still an important treatment. Gemcitabine (Gem) may prolong survival time and delay the development of recurrent disease after complete resection of pancreatic cancer. | Meta-analysis on resected pancreatic cancer A comparison between adjuvant treatments and gemcitabine alone

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN